A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer

Shinji Atagi; Masaaki Kawahara; Shigeto Hosoe; Mitsumasa Ogawara; Tomoya Kawaguchi; Kyoichi Okishio; Nobuyuki Naka; Toshihiko Sunami; Shigeki Mitsuoka; Masanori Akira

doi:10.1016/s0169-5002(01)00460-3

A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(01)00460-3 ◽

2002 ◽

Vol 36 (1) ◽

pp. 105-111 ◽

Cited By ~ 6

Author(s):

Shinji Atagi ◽

Masaaki Kawahara ◽

Shigeto Hosoe ◽

Mitsumasa Ogawara ◽

Tomoya Kawaguchi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

A phase II study of continuous concurrent thoracic radiotherapy (TRT) in combination with mitomycin (M), vindesine (V) and cisplatin (P) in unresectable stage III non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(00)80381-5 ◽

2000 ◽

Vol 29 (1) ◽

pp. 115

Author(s):

S Atagi ◽

M Kawahara ◽

S Hosoe ◽

M Ogawara ◽

H Ishikawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

A phase II study of cisplatin, S-1 and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7556 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7556-7556

Author(s):

F. Ohyanagi ◽

N. Yamamoto ◽

A. Horiike ◽

T. Horai ◽

T. Kozuka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

P2-217: Phase II study of TS-1(S) plus cisplatin(P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283925.92753.97 ◽

2007 ◽

Vol 2 (8) ◽

pp. S658 ◽

Cited By ~ 2

Author(s):

Toshiaki Takahashi ◽

Fumiyoshi Ohyanagi ◽

Atsushi Horiike ◽

Takeshi Horai ◽

Kotaro Gomi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Docetaxel plus cisplatin as neoadjuvant chemotherapy for unresectable stage III Non-Small-Cell Lung Cancer (NSCLC): A phase II study

Lung Cancer ◽

10.1016/s0169-5002(00)80374-8 ◽

2000 ◽

Vol 29 (1) ◽

pp. 113

Author(s):

M Dediu ◽

T Horvat ◽

A Tarlea ◽

A Nicodin ◽

M Movanu ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Phase II study of low-dose paclitaxel with timed thoracic radiotherapy (TTR) followed by gemcitabine and carboplatin consolidation in patients with unresectable stage III non-small cell lung cancer (NSCLC): NCT 00449657.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.7044 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 7044-7044

Author(s):

J. Zhang ◽

S. M. Russo ◽

H. A. Gay ◽

T. Parent ◽

Z. Nelson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Phase II study of weekly carboplatin/gemcitabine + concurrent thoracic radiotherapy (RT) followed by consolidation carboplatin/gemcitabine for inoperable stage III non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e18515 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e18515-e18515

Author(s):

Manuel Domine ◽

Cristina Carames Sanchez ◽

Francisco Lobo ◽

Tatiana Carolina Hernandez Guerrero ◽

Ana Leon ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

819 Induction carboplatin-paclitaxel-gemcitabine (CPG) followed by concurrent weekly carboplatin-paclifaxel (CP) and radiation therapy in unresectable stage iii non-small cell lung cancer (NSCLC). A phase II study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90844-5 ◽

2003 ◽

Vol 1 (5) ◽

pp. S246

Author(s):

O. Francesco ◽

A. Paccagnella ◽

S. Fasan ◽

S. Ardit ◽

C. Gatti ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non–Small-Cell Lung Cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

Journal of Thoracic Oncology ◽

10.1097/jto.0000000000000347 ◽

2015 ◽

Vol 10 (1) ◽

pp. 143-147 ◽

Cited By ~ 25

Author(s):

Rogerio Lilenbaum ◽

Michael Samuels ◽

Xiaofei Wang ◽

Feng Ming Kong ◽

Pasi A. Jänne ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2012.02.011 ◽

2012 ◽

Vol 77 (1) ◽

pp. 89-96 ◽

Cited By ~ 51

Author(s):

Luhua Wang ◽

Shixiu Wu ◽

Guangfei Ou ◽

Nan Bi ◽

Wenfeng Li ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2013.09.007 ◽

2014 ◽

Vol 83 (1) ◽

pp. 67-72

Author(s):

Jun Zhang ◽

Hiram A. Gay ◽

Suzanne Russo ◽

Teresa Parent ◽

Raid Aljumaily ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text